Cargando…
Thioredoxin Reductase Inhibitors as Potential Antitumors: Mercury Compounds Efficacy in Glioma Cells
Glioblastoma multiforme (GBM) is the most aggressive and common form of glioma. GBM, like many other tumors, expresses high levels of redox proteins, such as thioredoxin (Trx) and thioredoxin reductase (TrxR), allowing tumor cells to cope with high levels of reactive oxygen species (ROS) and resist...
Autores principales: | Pires, Vanessa, Bramatti, Isabella, Aschner, Michael, Branco, Vasco, Carvalho, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260667/ https://www.ncbi.nlm.nih.gov/pubmed/35813817 http://dx.doi.org/10.3389/fmolb.2022.889971 |
Ejemplares similares
-
Delivery of the selenoprotein thioredoxin reductase 1 to mammalian cells
por: Wright, David E., et al.
Publicado: (2022) -
Biomarkers of Adverse Response to Mercury: Histopathology versus Thioredoxin Reductase Activity
por: Branco, Vasco, et al.
Publicado: (2012) -
Editorial: Small molecule inhibitors targeting mammalian selenoprotein thioredoxin reductases (TXNRDs): Interactions, mechanisms, and applications
por: Xu, Jianqiang, et al.
Publicado: (2023) -
Inhibition of Thioredoxin Reductase by Santamarine Conferring Anticancer Effect in HeLa Cells
por: Zhang, Junmin, et al.
Publicado: (2021) -
Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway
por: Jiao, Wenxuan, et al.
Publicado: (2021)